Dermatology · Sacramento, CA
NPI
1528453701
Since 2015
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3301 C St Ste 1300
Sacramento, CA, 95816
Phone (916) 734-6111
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,341
38 services
Medicare patients, 2024
11
Average age 71
Drug cost, 2024
$580K
1,868 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie Feldstein prescribed most often to Medicare patients was Clobetasol Propionate, with 320 prescriptions and refills. In total Stephanie Feldstein wrote 1,868 Medicare prescriptions that cost $580K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 320 | 340 | 160 | $7,954 |
| Fluorouracil Generic | 308 | 331 | 220 | $13K |
| Triamcinolone Acetonide Generic | 107 | 110 | 81 | $2,724 |
| Hydrocortisone Generic | 83 | 87 | 47 | $1,387 |
| Doxycycline Monohydrate Generic | 80 | 140 | 45 | $2,784 |
| Tacrolimus Generic | 73 | 73 | 48 | $5,517 |
| Retin-A Tretinoin | 72 | 78 | 35 | $2,674 |
| Vectical Calcitriol | 65 | 68 | 54 | $12K |
| Calcipotriene Generic | 52 | 60 | 44 | $5,797 |
| Ketoconazole Generic | 51 | 61 | 26 | $946 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 43 | 43 | Under 11 | $188K |
| Hydroxyzine Hcl Generic | 37 | 41 | Under 11 | $255 |
| Imiquimod Generic | 35 | 43 | 23 | $972 |
| Mupirocin Generic | 33 | 39 | 25 | $648 |
| Metronidazole Generic | 32 | 33 | 18 | $678 |
Brand drugs: 263 claims; generic drugs: 1,605 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Stephanie Feldstein were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.